PPARG and hepatoblastoma: In liver hepatoblastoma cells, a recent study demonstrated that spheroid formation was rescued by treatment with the PPAR-γ antagonist GW9662 in BEX1 knockout cells, suggesting that BEX1 promoted the maintenance of hepatoblastoma stemness by inhibiting PPAR-γ [140].